PharVision Advisers’s Phreesia PHR Stock Holding History

PharVision Advisers’s Portfolio PHR Stock Details PHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,833	Closed	-$99.2K	–	112
2026 Q1	$99.2K	Sell	11,833 -9,803	-45%	-$130K	1.01%	47
2025 Q4	$366K	Buy	21,636 +6,982	+48%	+$144K	0.19%	158
2025 Q3	$345K	Buy	+14,654	New	+$399K	0.19%	146
2025 Q2	–	Sell	-8,622	Closed	-$220K	–	389
2025 Q1	$220K	Sell	8,622 -3,384	-28%	-$92K	0.31%	169
2024 Q4	$302K	Buy	+12,006	New	+$257K	0.26%	149

Other funds holding PHR

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

PharVision Advisers's PHR Position: Q2 2026 in Review

PharVision Advisers sold out of Phreesia (PHR) in Q2 2026, closing a stake of 11,833 shares — an estimated $99.2K sold.

PharVision Advisers first reported a position in PHR in Q4 2024 and held it in 5 quarters. The position peaked at $366K in Q4 2025. 227 funds tracked by Wall St. Rank hold PHR as of Q2 2026.

PharVision Advisers reported no remaining Phreesia position as of Q2 2026 after selling out during the quarter.
PharVision Advisers sold 11,833 Phreesia shares in Q2 2026, an estimated $99.2K.
PharVision Advisers first reported a position in Phreesia in Q4 2024 and held it in 5 quarters.
PharVision Advisers's Phreesia position peaked at $366K in Q4 2025.
227 funds tracked by Wall St. Rank held Phreesia as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.